Targeting C5a/C5aR1 signaling ameliorates COVID-19 immunopathology - News-Medical.Net

7/6/2022 12:00:00 AM2 years 9 months ago

A new study investigated the role of complement component 5a (C5a) and its receptor (C5a receptor type 1, C5aR1) in the pathophysiology of COVID-19.

A recent study posted to the bioRxiv* preprint server investigated the role of complement component 5a (C5a) and its receptor (C5a receptor type 1, C5aR1) in the pathophysiology of coronavirus diseas… [+6041 chars]

full article...